AR065966A1 - Sulfonamidas substituidas, proceso para su preparacion, composicion farmaceutica de las mismas y su uso - Google Patents
Sulfonamidas substituidas, proceso para su preparacion, composicion farmaceutica de las mismas y su usoInfo
- Publication number
- AR065966A1 AR065966A1 ARP080101430A ARP080101430A AR065966A1 AR 065966 A1 AR065966 A1 AR 065966A1 AR P080101430 A ARP080101430 A AR P080101430A AR P080101430 A ARP080101430 A AR P080101430A AR 065966 A1 AR065966 A1 AR 065966A1
- Authority
- AR
- Argentina
- Prior art keywords
- same
- substituted
- sulfonamids
- preparation
- pharmaceutical composition
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- -1 4- (N, N-diethylaminoethoxy) benzyl Chemical group 0.000 abstract 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- LLFQHNCOIPUFIJ-UHFFFAOYSA-N 4-sulfamoylbenzenesulfonyl chloride Chemical compound NS(=O)(=O)C1=CC=C(S(Cl)(=O)=O)C=C1 LLFQHNCOIPUFIJ-UHFFFAOYSA-N 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 210000003041 ligament Anatomy 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000007344 nucleophilic reaction Methods 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 229940124530 sulfonamide Drugs 0.000 abstract 1
- 150000003456 sulfonamides Chemical group 0.000 abstract 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/17—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/18—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Que resultan de utilidad en la fabricacion de los medicamentos debido a la inhibicion de la carboanhidrasa. Estos compuestos se preparan por reaccion nucleofílica de un amino con cloruro de 4-sulfamoilbenzenosulfonil en presencia de exceso detrietilamina en tetrahidrofurano o en éter a temperatura 0 a 20 °C. Los compuestos muestran una actividad antiglaucomática. Reivindicacion 1: Sulfonamidas substituidas con la formula general (1) donde: R1 es CO o SO2, R2 es NH o O, R incluye ungrupo terciario diC1-4alquilamino, donde las mitades de alquiles son las mismas o diferentes, o un grupo amino, cuyas mitades de alquiles forman entre sí un anillo saturado de 5, 6 y 7 miembros, o sus extremos están unidos por un heteroátomo O, o Res 4-(N,N-dietilaminoetoxi)benzil cuando R1 es SO2 y R2 es NH; o R es 4-[N-(morfolinopropil)sulfamoil]fenil cuando R1 es CO y R2 es NH. n es un numero de carbonos de una cadena alifática de ligamento, que es lineal o ramificada, donde n es 0, 2 o 3.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SK54-2007A SK542007A3 (sk) | 2007-04-20 | 2007-04-20 | Substituované sulfónamidy, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR065966A1 true AR065966A1 (es) | 2009-07-15 |
Family
ID=39671772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080101430A AR065966A1 (es) | 2007-04-20 | 2008-04-04 | Sulfonamidas substituidas, proceso para su preparacion, composicion farmaceutica de las mismas y su uso |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US8193184B2 (es) |
| EP (1) | EP2142499B1 (es) |
| JP (1) | JP5492764B2 (es) |
| CN (1) | CN101663267A (es) |
| AR (1) | AR065966A1 (es) |
| AU (1) | AU2008241590B2 (es) |
| BR (1) | BRPI0809728A2 (es) |
| CA (1) | CA2684591C (es) |
| CL (1) | CL2008001109A1 (es) |
| DK (1) | DK2142499T3 (es) |
| ES (1) | ES2528284T3 (es) |
| HR (1) | HRP20141246T1 (es) |
| HU (1) | HUE024552T2 (es) |
| IL (1) | IL200952A0 (es) |
| JO (1) | JO3206B1 (es) |
| MA (1) | MA31364B1 (es) |
| MX (1) | MX2009010528A (es) |
| NZ (1) | NZ581302A (es) |
| PE (1) | PE20090807A1 (es) |
| PL (1) | PL2142499T3 (es) |
| PT (1) | PT2142499E (es) |
| RU (1) | RU2474574C2 (es) |
| SA (1) | SA08290238B1 (es) |
| SI (1) | SI2142499T1 (es) |
| SK (1) | SK542007A3 (es) |
| TN (1) | TN2009000421A1 (es) |
| TW (1) | TWI392492B (es) |
| UA (1) | UA99279C2 (es) |
| UY (1) | UY31028A1 (es) |
| WO (1) | WO2008130332A1 (es) |
| ZA (1) | ZA200906305B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115141128B (zh) * | 2022-06-24 | 2024-09-13 | 沈阳药科大学 | 3-芳基-3-(磺胺苯甲酰胺基)丙(烯)酸衍生物及其制备方法及应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2789938A (en) * | 1952-11-24 | 1957-04-23 | Merck & Co Inc | Method of producing a diuretic effect with p-carboxybenzenesulfonamide |
| CH451142A (de) * | 1965-01-19 | 1968-05-15 | Sandoz Ag | Verfahren zur Herstellung neuer basisch substituierter Benzoesäureamide |
| GB1523631A (en) * | 1975-07-08 | 1978-09-06 | Leo Pharm Prod Ltd | Sulphonamide derivatives |
| EP0029090A3 (en) * | 1979-09-28 | 1981-07-01 | American Cyanamid Company | Sulfon amides containing a hindered phenol; stabilized composition containing a synthetic polymer and said sulfon amides |
| FR2504528A1 (fr) * | 1981-04-23 | 1982-10-29 | Choay Sa | Dialcoxy (2,4) benzenesulfonamides n-substitues |
| JPS5939867A (ja) * | 1982-08-27 | 1984-03-05 | Fuji Yakuhin Kogyo Kk | ２−クロロスルホニル−４−ｎ−置換スルフアミル−クロロベンゼンの製造法 |
| JPS6041071B2 (ja) * | 1983-07-28 | 1985-09-13 | ソシエテ・デチユ−デ・シヤンテイフイツク・エ・アンデユストリエル・ドウ・リル−ドウ−フランス | 安息香酸誘導体 |
| US4678855A (en) * | 1985-10-09 | 1987-07-07 | Merck & Co., Inc. | Substituted benzenesulfonamides |
| US4721809A (en) * | 1986-09-18 | 1988-01-26 | American Home Products Corporation | Alkylsulfonamido or perfluoroalkylsulfonamido benzenesulfonamides |
| JPH09510442A (ja) * | 1994-03-11 | 1997-10-21 | ファーマコペイア，インコーポレイテッド | スルホンアミド誘導体及びそれらの使用 |
| JP2001162950A (ja) * | 1999-12-13 | 2001-06-19 | Fuji Photo Film Co Ltd | 感熱記録材料 |
| JP4139712B2 (ja) * | 2002-03-14 | 2008-08-27 | ライオン株式会社 | 漂白活性化剤及び漂白剤組成物 |
| EP2377569A1 (en) * | 2004-07-02 | 2011-10-19 | QLT Plug Delivery, Inc. | Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device |
| SE0401969D0 (sv) * | 2004-08-02 | 2004-08-02 | Astrazeneca Ab | Piperidine derivatives |
| WO2008071421A1 (en) * | 2006-12-15 | 2008-06-19 | Nicox S.A. | Nitrate esters of carbonic anhydrase inhibitors |
-
2007
- 2007-04-20 SK SK54-2007A patent/SK542007A3/sk unknown
-
2008
- 2008-03-11 TW TW097108546A patent/TWI392492B/zh not_active IP Right Cessation
- 2008-04-04 AR ARP080101430A patent/AR065966A1/es unknown
- 2008-04-17 UY UY31028A patent/UY31028A1/es not_active Application Discontinuation
- 2008-04-17 JO JOP/2008/0180A patent/JO3206B1/ar active
- 2008-04-18 EP EP08741979.2A patent/EP2142499B1/en active Active
- 2008-04-18 JP JP2010504023A patent/JP5492764B2/ja not_active Expired - Fee Related
- 2008-04-18 NZ NZ581302A patent/NZ581302A/en not_active IP Right Cessation
- 2008-04-18 PT PT87419792T patent/PT2142499E/pt unknown
- 2008-04-18 WO PCT/SK2008/050005 patent/WO2008130332A1/en not_active Ceased
- 2008-04-18 SI SI200831379T patent/SI2142499T1/sl unknown
- 2008-04-18 HU HUE08741979A patent/HUE024552T2/hu unknown
- 2008-04-18 BR BRPI0809728A patent/BRPI0809728A2/pt not_active IP Right Cessation
- 2008-04-18 CL CL2008001109A patent/CL2008001109A1/es unknown
- 2008-04-18 RU RU2009134079/04A patent/RU2474574C2/ru not_active IP Right Cessation
- 2008-04-18 PL PL08741979T patent/PL2142499T3/pl unknown
- 2008-04-18 UA UAA200910016A patent/UA99279C2/ru unknown
- 2008-04-18 CA CA2684591A patent/CA2684591C/en not_active Expired - Fee Related
- 2008-04-18 PE PE2008000680A patent/PE20090807A1/es not_active Application Discontinuation
- 2008-04-18 AU AU2008241590A patent/AU2008241590B2/en not_active Ceased
- 2008-04-18 ES ES08741979.2T patent/ES2528284T3/es active Active
- 2008-04-18 CN CN200880012806A patent/CN101663267A/zh active Pending
- 2008-04-18 DK DK08741979.2T patent/DK2142499T3/en active
- 2008-04-18 MX MX2009010528A patent/MX2009010528A/es active IP Right Grant
- 2008-04-18 HR HRP20141246AT patent/HRP20141246T1/hr unknown
- 2008-04-19 SA SA08290238A patent/SA08290238B1/ar unknown
- 2008-04-20 US US12/596,820 patent/US8193184B2/en not_active Expired - Fee Related
-
2009
- 2009-09-10 ZA ZA200906305A patent/ZA200906305B/xx unknown
- 2009-09-15 IL IL200952A patent/IL200952A0/en not_active IP Right Cessation
- 2009-10-13 TN TNP2009000421A patent/TN2009000421A1/fr unknown
- 2009-11-05 MA MA32329A patent/MA31364B1/fr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP056105A (es) | Acidos carboxilicos alfa sustituidos como moduladores ppar | |
| DK1981874T3 (da) | Aminophenylderivater som nye inhibitorer af histondeacetylase | |
| CO2018005848A2 (es) | Compuestos de pirazol o sus sales, métodos de preparación de los mismos, composiciones herbicidas y su uso | |
| UY28915A1 (es) | Derivados de tetraazabenzo (e)azuleno y sus análogos | |
| CR20190039A (es) | ACETAMIDAS SUSTITUIDAS POR N-(HETERO)-ARILO Y 2-(HETERO)-ARILO (Divisional 2011-0520) | |
| CL2008002132A1 (es) | Compuestos derivados de sulfonamidas, moduladores de trpm8; composiciones farmaceuticas que comprenden a dichos compuestos; y uso de dichos compuestos en el tratamiento del dolor neuropatico, dolor inflamatorio, ansiedad, depresion, hiperalgesia inflamatoria, entre otras. | |
| NZ517696A (en) | Biaryl ether derivatives useful as monoamine reuptake inhibitors | |
| NO20075051L (no) | Nye sulfonylpyrroler og deres anvendelse som histon-deacetylaseinhibitorer | |
| BRPI0512676B8 (pt) | derivados de indolil alquil amina substituídos como inibidores de histona desacetilase, composição farmacêutica que os compreende, seus processos de preparação e uso | |
| AR048086A1 (es) | Bencenodicarboxamidas insecticidas | |
| AR049401A1 (es) | Aza-biciclononanos | |
| AR049578A1 (es) | Derivados de hidantoina, procesos de obtencion y composiciones farmaceuticas | |
| ATE487608T1 (de) | Reversible thermochrome zusammensetzungen | |
| CL2023000223A1 (es) | Nuevos inhibidores selectivos de hdac6 basados en oxadiazol | |
| ECSP055743A (es) | Nuevo proceso para la sintesis industrial de tetraésteres del acido 5-[bis(carboximetil)amino]-3-carboximetil-4-ciano-2- tiofeno carboxílico y aplicación para la síntesis de sales bivalentes de acido ranelico y sus hidratos | |
| CO6320143A1 (es) | Nuevos derivados dihidroindolonas su procedimeinto de preparacion y composiciones farmaceuticas que los contienen | |
| SV2004001555A (es) | Difenilazetidinonas cationicamente sustituidas, procesos para su preparacion, medicamentos que contienen estos compuestos y sus usos | |
| EA200600878A1 (ru) | Производные феноксиуксусных кислот, применимые в качестве двойных агонистов активируемого пероксисомным пролифератором рецептора ( ppar ) | |
| ECSP055986A (es) | Derivados de ácido 3-(2-fenil-oxazol-4-ilmetoxi)ciclohexilmetoxiacético y compuestos relacionados utilizados como moduladores de ppar para tratar diabetes de tipo 2 y arterioesclerosis | |
| UY28765A1 (es) | Compuestos de piperazina acetilínica y su uso como antagonistas del receptor de glutamato metabotrópico | |
| CR9499A (es) | Nuevos derivados de fenilpiridinilpiperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| HRP20080174A2 (hr) | Derivati benzotiazol ciklobutil amina i njihova uporaba kao liganda histamin-3-receptora | |
| AR065966A1 (es) | Sulfonamidas substituidas, proceso para su preparacion, composicion farmaceutica de las mismas y su uso | |
| PE20061446A1 (es) | Compuestos de bencimidazol-carboxamida como agonistas de receptores 5-ht4 | |
| BRPI0508471A8 (pt) | compostos de hidróxi-6-fenilfenantidinas substituídas por difluoroetóxi, composição farmacêutica e uso para a produção dos mesmos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |